Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Carbapenemase-producing organisms (CPO) are rapidly disseminating worldwide, and their presence in tertiary care hospitals poses a significant threat to the management of nosocomial infections. There is a need to control CPO, especially in intensive care unit (ICU) patients, because these organisms are resistant to most β-lactam antibiotics and are easily transmitted. At present, the identification of CPO is time-consuming; hence, this study focused on the use of the Xpert CARBA-R assay (Cepheid, USA) to determine intestinal colonization rates of CPO in patients admitted to the ICU of a tertiary care hospital in Korea. Forty clinical stool samples were collected and inoculated both in a CARBA-R cartridge and in conventional culture plates. The CARBA-R assay required only ~one hour to screen CPO, while the time required for conventional culture was over three days. We also found that the prevalences of intestinal colonization by carbapenem-resistant organisms and Enterobacteriaceae were 17.5% (7 out of 40) and 7.5% (3 out of 40), respectively. Among the colonizing strains, three that contained carbapenemase, including Klebsiella pneumonia carbapenemase (KPC), and imipenem (IMP) and Verona integron-mediated metallo-β-lactamase (VIM) were found. With its convenience, the Xpert CARBA-R assay can be included in CPO surveillance strategies.
Abstract
Carbapenemase-producing organisms (CPO) are rapidly disseminating worldwide, and their presence in tertiary care hospitals poses a significant threat to the management of nosocomial infections. There is a need to control CPO, especially in intensive care unit (ICU) patients, because these organisms are resistant to most β-lactam antibiotics and are easily transmitted. At present, the identification of CPO is time-consuming; hence, this study focused on the use of the Xpert CARBA-R assay (Cepheid, USA) to determine intestinal colonization rates of CPO in patients admitted to the ICU of a tertiary care hospital in Korea. Forty clinical stool samples were collected and inoculated both in a CARBA-R cartridge and in conventional culture plates. The CARBA-R assay required only ~one hour to screen CPO, while the time required for conventional culture was over three days. We also found that the prevalences of intestinal colonization by carbapenem-resistant organisms and Enterobacteriaceae were 17.5% (7 out of 40) and 7.5% (3 out of 40), respectively. Among the colonizing strains, three that contained carbapenemase, including Klebsiella pneumonia carbapenemase (KPC), and imipenem (IMP) and Verona integron-mediated metallo-β-lactamase (VIM) were found. With its convenience, the Xpert CARBA-R assay can be included in CPO surveillance strategies.
참고문헌 (19)
- 정윤섭, "Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non- Typhoidal Salmonella Species", Infection and Chemotherapy, 46(2), pp.84~93 (2014), 대한감염학회
- 정혜선, "Characterization of the Multidrug-Resistant Acinetobacter species Causing a Nosocomial Outbreak at Intensive Care Units in a Korean Teaching Hospital: Suggesting the Correlations with the Clinical and Environmental Samples, Including Respiratory Tract-related Instruments", Annals of Clinical Microbiology, 17(2), pp.29~34 (2014), 대한임상미생물학회
- Cornaglia G, "Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase", Clin Infect Dis, 31, pp.1119~1125 (2000)
- Gregory CJ, "Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant", Infect Control Hosp Epidemiol, 31, pp.476~484 (2010)
- Woodford N, "Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center", Antimicrob Agents Chemother, 48, pp.4793~4799 (2004)
- Gibb AP, "Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7)", Antimicrob Agents Chemother, 46, pp.255~258 (2002)
- Tokatlidou D, "Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital", J Clin Microbiol, 46, pp.1005~1008 (2008)
- Wrenn C, "Investigation of the first outbreak of OXA-48-producing Klebsiella in Ireland", J Hosp Infect, 87, pp.41~46 (2014)
- Borer A, "Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae", Am J Infect Control, 40, pp.421~425 (2012)
- Tacconelli E, "ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients", Clin Microbiol Infect, 20, pp.S1~S55 (2014)
- 김자영, "Rates of Fecal Transmission of Extended-Spectrum β-Lactamase-Producing and Carbapenem-Resistant Enterobacteriaceae Among Patients in Intensive Care Units in Korea", Annals of Laboratory Medicine, 34(1), pp.20~25 (2014), 대한진단검사의학회
- Zhao ZC, "Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital", Am J Infect Control, 42, pp.e61~e64 (2014)
- Tenover FC, "Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay", J Clin Microbiol, 51, pp.3780~3787 (2013)
- 송원근, "Combined Use of the Modified Hodge Test and Carbapenemase Inhibition Test for Detection of Carbapenemase-Producing Enterobacteriaceae and Metallo-β-Lactamase-Producing Pseudomonas spp.", Annals of Laboratory Medicine, 35(2), pp.212~219 (2015), 대한진단검사의학회
- Lee W, "Comparison of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry assay with conventional methods for detection of IMP-6, VIM-2, NDM-1, SIM-1, KPC-1, OXA-23, and OXA-51 carbapenemase-producing Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella pneumoniae", Diagn Microbiol Infect Dis, 77, pp.227~230 (2013)
- 박연준, "Enterobacteriaceae에 대한 β-Lactam제 감수성시험 기준 및 Extended-Spectrum β-Lactamase와 Carbapenemase 검출을 위한 전략", Annals of Clinical Microbiology, 16(3), pp.111~119 (2013), 대한임상미생물학회
- Seah C, "Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae", J Clin Microbiol, 49, pp.1965~1969 (2011)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility tsting", Clinical and Laboratory Standards Institues, ~ (2014)
- Decousser JW, "Failure to detect carbapenem-resistant Escherichia coli producing OXA-48-like using the Xpert Carba-R assay", Clin Microbiol Infect, 21, pp.e9~e10 (2015)